Phlox Therapeutics

Naarden, The Netherlands

Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.

Nov 2024

Grant

Biotechnology Genetics Medical Therapeutics

Top Investors

ROM Utrecht Region NWO Utrecht Health Seed Fund Amsterdam UMC Ventures First

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Phlox Therapeutics

Who are Phlox Therapeutics's investors?

Phlox Therapeutics's investors include ROM Utrecht Region, NWO, Utrecht Health Seed Fund, Amsterdam UMC Ventures, First.

Where is Phlox Therapeutics headquartered?

Phlox Therapeutics is headquartered in Naarden, The Netherlands.

What does Phlox Therapeutics do?

Phlox Therapeutics specializes in the development of gene therapy to alleviate and cure cardiomyopathies.

What stage is Phlox Therapeutics at?

Phlox Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 13, 2024.

MLA

"Phlox Therapeutics — Funding & Investors." VCBacked, November 13, 2024, https://www.vcbacked.co/company/phlox-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). Phlox Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/phlox-therapeutics

Wikipedia (cite web)

{{cite web |title=Phlox Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/phlox-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 13, 2024.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K